Louis J Lavigne Jr's Net Worth

$43.8 Million

Estimate Recalculated Nov 7, 2024 12:16PM EST

Who is Louis J Lavigne Jr?

Louis J Lavigne Jr has an estimated net worth of $43.8 Million. This is based on reported shares across multiple companies, which include ZYNGA INC, EQUINIX INC, DOCUSIGN INC, KYPHON INC, ARENA PHARMACEUTICALS INC, NovoCure Ltd, Alector, Inc., ACCURAY INC, ALLERGAN INC, BMC SOFTWARE INC, DEPOMED INC, and GENENTECH INC.

SEC CIK

Louis J Lavigne Jr's CIK is 0001214127

Past Insider Trading and Trends

2004 was Louis J Lavigne Jr's most active year for acquiring shares with 119 total transactions. Louis J Lavigne Jr's most active month to acquire stocks was the month of December. 2004 was Louis J Lavigne Jr's most active year for disposing of shares, totalling 232 transactions. Louis J Lavigne Jr's most active month to dispose stocks was the month of December. 2004 saw Louis J Lavigne Jr paying a total of $10,415,500.00 for 845,000 shares, this is the most they've acquired in one year. In 2004 Louis J Lavigne Jr cashed out on 1,200,000 shares for a total of $42,867,541.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZYNGA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-284.06K
—
—
0
May 23
Form 4
∞
5.55K
—
—
5.55K
May 17
Form 4
∞
8.21K
—
—
8.21K
Feb 7
Form 4
+2.83%
8.21K
—
—
298.08K
Nov 1 - Nov 7
Form 4
+2.91%
8.21K
—
—
289.87K
Aug 7
Form 4
—
0
—
—
0
May 7
Form 4
+5.44%
14.54K
—
—
281.66K
Apr 26
Form 4
+5.75%
14.54K
—
—
267.13K
Jan 26
Form 4
+6.11%
14.54K
—
—
252.59K
Oct 26
Form 4
+6.50%
14.53K
—
—
238.06K
Jul 26
Form 4
+8.45%
17.42K
—
—
223.52K
Apr 26
Form 4
+9.23%
17.42K
—
—
206.1K
Feb 1
Form 4
+10.17%
17.42K
—
—
188.68K
Nov 1
Form 4
+11.32%
17.42K
—
—
171.26K
Aug 1
Form 4
+14.16%
19.08K
—
—
153.84K
May 1
Form 4
+16.50%
19.08K
—
—
134.75K
Mar 9
Form 4
+19.76%
19.08K
—
—
115.67K
Dec 9
Form 4
+24.62%
19.08K
—
—
96.58K
Sep 9
Form 4
+27.51%
16.72K
—
—
77.5K
Jun 9
Form 4
+37.94%
16.72K
—
—
60.8K
Mar 11
Form 4
+61.17%
16.72K
—
—
44.06K
Dec 11
Form 4
+157.59%
16.72K
—
—
27.34K
Sep 11
Form 4
—
0
—
—
0
Jun 11
Form 4
∞
10.61K
—
—
10.61K
Jun 10
Form 4
—
0
—
—
0
Apr 23
Form 3
—
0
—
—
0
No matching records found

EQUINIX INC (EQIX) Snapshot price: $818.31

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

DOCUSIGN INC (DOCU) Snapshot price: $58.5115

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.73%
3.79K
—
—
16.54K
Jun 17
Form 4
+10.58%
3.77K
—
—
39.4K
Jul 18
Form 4
+235.88%
89.81K
—
—
127.88K
May 1
Form 3
—
0
—
—
0
No matching records found

KYPHON INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-300.00
—
—
0
Nov 2
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

ARENA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 28
Form 4
—
0
—
—
0
Jan 17
Form 3
—
0
—
—
0
No matching records found